NuPathe, Inc. (PATH) Reports In-Line Q3 Loss of 51c/Share
- Dow, S&P futures inch higher as banks, energy stocks jump
- EV Company Polestar To Go Public Via $20 Billion SPAC Deal
- Amazon (AMZN) Price Target Lowered at Morgan Stanley Amid Rising Logistics Workforce Costs, Analyst Expects Stock to be Range Bound in Near Term
- Acceleron Pharma (XLRN) Said in Advanced Talks for $11 Billion Sale - Bloomberg (Earlier)
- Brent oil nears $80 a barrel amid supply constraints
NuPathe, Inc. (NASDAQ: PATH) reported Q3 EPS of ($0.51), in-line with the analyst estimate of ($0.51).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIOs Believe Automation is Imperative to Solve Productivity Challenges and Accelerate Digital Transformation
- Carnival says cruise bookings for 2022 second half above pre-pandemic levels
- HIVE Blockchain Technologies (HIVE) Announces Record FY Revenues of $66.7M; Net Income of $42.5M
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!